Skip to main content
. Author manuscript; available in PMC: 2014 May 30.
Published in final edited form as: South Med J. 2010 Sep;103(9):887–891. doi: 10.1097/SMJ.0b013e3181eb5649

Table 3.

Medications and laboratory values for each patient at the time of hemoptysis

Patient Episode ERA PDE-5 I Digoxin Warfarin Platelets (microliter) INR (unit) BUN (mg/ dL) Creatinine (mg/dL)
A 1 No No Yes No 72 1 16 1.3
2 No No Yes No 63 1.1 17 1.4
3 No No Yes No 61 1.1 14 1
4 No Sildenafil Yes No 107 1.1 15 1.2
5 No Sildenafil Yes No 90 1 17 1.1
6 No Sildenafil Yes No 106 1 16 1.2
7 No Sildenafil Yes No 151 1.1 15 0.8
8 No Sildenafil Yes No 129 1.1 13 1.1
9 No Sildenafil Yes No 118 1.1 17 0.9
B 1 No No Yes No 172 0.9 22 1
C 1 No No Yes No 165 1.1 15 1
D 1 No No Yes No 161 1.3 11 1
2 No No Yes No 214 1.3 10 0.9

ERA, endothelin receptor antagonist; PDE5-I, phosphodiesterase 5-inhibitor.